This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford-Jones, E. L.
Right arrow Articles by Naus, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford-Jones, E. L.
Right arrow Articles by Naus, M.
Related Collections
Right arrow West Nile Virus
CMAJ • January 8, 2002; 166 (1)
© 2002 Canadian Medical Association or its licensors


Research
Recherche

Human surveillance for West Nile virus infection in Ontario in 2000

E. Lee Ford-Jones*, Margaret Fearon{dagger}, Chuck Leber{dagger}, Prabo Dwight{dagger}, Moira Myszak*{dagger}, Beverly Cole*{dagger}, Pam Baker Greene*{dagger}, Sheila Artes{dagger}, Allison McGeer{ddagger}, Colin D'Cunha{dagger}, Monika Naus{dagger} and The Ontario West Nile Virus Working Group§

From *the Hospital for Sick Children, University of Toronto, {dagger}the Ontario Ministry of Health and Long-term Care, and {ddagger}Mount Sinai Hospital, Toronto, Ont.Ontario West Nile Virus Working Group: Members: Chuck Leber (chair), Ontario Ministry of Health and Long-Term Care, Toronto, Ont.; Pam Baker Greene, Beverly Cole, E. Lee Ford-Jones and Moira Myszak, Hospital for Sick Children, Toronto, Ont.; Allison McGeer, Mount Sinai Hospital, Toronto, Ont.; and Sheila Artes, Colin D'Cunha, Prabo Dwight, Margaret Fearon and Monika Naus (project director), Ontario Ministry of Health and Long-Term Care, Toronto, Ont. Project Team (Advisory Group): David Alves, Ontario Ministry of Agriculture, Food and Rural Affairs, Toronto, Ont.; Sharon Balsys, Bill Hunter and Kim Murray Perrault, Ontario Ministry of Health and Long-Term Care, Toronto, Ont.; Ian Barker, Doug Campbell and James Heal, University of Guelph, Guelph, Ont.; Howard Barton and Larry Clay, Ontario Ministry of Municipal Affairs and Housing, Toronto, Ont.; Geoff Cutten, Ontario Ministry of the Environment, Toronto, Ont.; Shelley Deeks, City of Toronto Public Health, Toronto, Ont.; Alex Hukowich, Haliburton, Kawartha and Pine Ridge District Health Unit, Port Hope, Ont.; Robbin Lindsay, Health Canada, Ottawa, Ont.; Rick Rosatte and Roxanne St. Martin, Ontario Ministry of Natural Resources, Toronto, Ont.; Nina Szpakowski, Canadian Food Inspection Agency; and Robert Thompson, Wellington, Dufferin and Guelph Health Unit, Guelph, Ont.

Correspondence to: Dr. E. Lee Ford-Jones, Division of Infectious Diseases, Hospital for Sick Children, 555 University Ave., Toronto ON M5G 1X8

Background: The first reports of West Nile virus (WNV) infection in the United States in 1999 prompted Ontario to establish a surveillance protocol to monitor for the possible spread of the virus into the province. Surveillance components included evaluation of dead birds, sentinel chickens, mosquito pools and human disease. We report the results of human surveillance in 2000.

Methods: Between July 1 and Oct. 31, 2000, an active surveillance program was undertaken in which designated site coordinators in sentinel hospitals identified patients who met the suspect case definition (fever and fluctuating level of consciousness [encephalopathy], with or without muscle weakness). During the same period, following province-wide distribution of educational material, all other patients tested for WNV antibodies were identified through review of provincial laboratory reports (laboratory-based enhanced passive surveillance).

Results: Of the 60 hospitals contacted, 59 agreed to participate in the active surveillance program; 52 provided information on a regular (weekly) basis, and 7 submitted fewer than 8 reports. Thirty-six (61%) of the sentinel sites reported suspect cases. In total, 188 patients were tested (130 identified through active surveillance and 58 through enhanced passive surveillance). Patients identified through active surveillance were more likely than those identified through passive surveillance to meet the suspect case definition (43% [n = 56] v. 7% [n = 4]), to be admitted to hospital (75% [n = 99] v. 16% [n = 9]), to have a longer hospital stay (mean 25 v. 3 days), to have had a second (convalescent) serum sample collected (37% [n = 48] v. 31% [n = 18]), to have had a cerebrospinal fluid (CSF) sample banked (56% [n = 73] v. 14% [n = 8]) and to have had a discharge diagnosis reported (79% [n = 103] v. 28% [n = 16]). Of the 60 patients (32%) who met the suspect case definition, 34 (57% [31 active, 3 passive]) had a discharge diagnosis of encephalitis. Of these, 17 (50% [15 active, 2 passive]) had paired serum samples collected, and 18 (51% [all active]) had a CSF sample banked. The reported causal agents were herpes simplex virus (n = 8), varicella virus (n = 2), Powassan virus (n = 1), echovirus 30 (n = 1) and group B Streptococcus (n = 1); the cause was unknown in 18 cases. One patient died of encephalitis. The remaining 26 patients who met the suspect case definition were ultimately found to have nonencephalitic infections, vascular events or alcohol- or drug-related illness. The 128 (68%) tested for WNV who did not meet the suspect case definition included 9 patients ultimately discharged with a diagnosis of encephalitis. No cases of WNV infection were identified.

Interpretation: Only one-third of the tested patients met the suspect case definition of encephalopathy on admission, and nearly half of them were later found to have another diagnosis; others did not meet the case definition but were later discharged with a diagnosis of encephalitis. This affirms that identification of acute encephalitis on the basis of symptoms at the time of admission is often impossible.





This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
L. R. Petersen and A. A. Marfin
West Nile Virus: A Primer for the Clinician
Ann Intern Med, August 6, 2002; 137(3): 173 - 179.
[Abstract] [Full Text] [PDF]